Devices and Research News

SEATTLE, Wash. (SEND2PRESS NEWSWIRE) -- VitalStim(R) Therapy is a patented-therapy process and equipment system developed specifically to treat dysphagia and patients with difficulty swallowing. And, it's safe and effective. Developed by Marcy L. Freed, MA, CCC-SLP, in response to reports that approximately 15 million Americans live with dysphagia, VitalStim Therapy is a non-invasive, external electrical stimulation therapy cleared to market, in December 2002, by the Food and Drug Administration (FDA).

And, it's the only Neuromuscular Electrical Stimulation (NMES) therapy that has received such FDA clearance for dysphagia.

VitalStim Therapy, backed by comprehensive data from 892 clincial patient trials, applies specifically-designed electrodes to the muscles of the throat to promote proper swallowing. It does this through muscle re-education.

Designed as an adjunct therapy, VitalStim Therapy works together with swallowing-related exercises. Through various studies, it has demonstrated its ability to yield positive results.

In a three-year follow-up study, VitalStim Therapy was proven to accelerate recovery time from a restricted diet and also helped patients to achieve sustained improvement and long-term results.

Most recently, a second published study demonstrated the lasting positive impact of VitalStim Therapy in a group of patients who had experienced failed dysphagia therapy.

To date, VitalStim Therapy has been referenced in a best-selling, self-help book on stroke recovery. Articles have appeared in numerous publications such as The Boston Globe and The Los Angeles Times in addition to many hospital and health care reports.

About the Founder:

Marcy L. Freed, MA, CCC-SLP, founder of VitalStim Technologies LLC, has changed the face of dysphagia therapy through this medical breakthrough approach that combines traditional dysphagia therapy with NMES. With 32 years of experience, Freed specializes in voice and swallowing intervention and is currently a speech-language pathologist with the University Hospital of Cleveland.

For more information, visit: www.VitalStim.com .


NEWS SOURCE: VitalStim, LLC

Send2Press® is the originating wire service for this story.

PRESS RELEASE PERMALINK: http://www.send2press.com/newswire/2010-03-0303-001.shtml

For more information about this news release, contact VitalStim, LLC directly through their Web site found in the above press release, and NOT Send2Press.

Copyright © 2010 by Send2Press® Newswire, part of the Neotrope® News Network (California, USA). All rights reserved. License/Terms of Use: Attribution Required ("Send2Press® is the originating wire service").